Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Schiff

Showing results (91-100 of 305) with videos related to

Pageof 31
Sort By:
Current Oncology Reports|July 20, 2023
Disease Assessments in Patients with GlioblastomaKester A Phillips, David O Kamson, David Schiff
The Lancet. Neurology|October 22, 2005
Low-grade gliomas: an update on pathology and therapyRobert Cavaliere, Maria Beatriz S Lopes, David Schiff
Cancer|January 7, 2010
Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group ReportRobert Cavaliere, Gina Petroni, Maria B Lopes, et al.
CNS Oncology|October 17, 2017
Regression of an intramedullary spinal cord metastasis with a checkpoint inhibitor: a case reportKester A Phillips, Elizabeth Gaughan, Alejandro Gru, et al.
Surgical Neurology|September 11, 2007
Bone health in patients with brain tumorsArnaldo Neves Da Silva, Ailleen Heras-Herzig, David Schiff
Hematology/Oncology Clinics of North America|October 5, 2021
Central Nervous System Complications Among Oncology PatientsSebastian F Winter, Jasmin Jo, David Schiff, et al.
Endocrine|November 29, 2005
Pituitary carcinoma: diagnosis and treatmentM Beatriz S Lopes, Bernd W Scheithauer, David Schiff
Neuro-Oncology|June 27, 2015
Much debated controversies of diffuse low-grade gliomasGelareh Zadeh, Osaama H Khan, Michael Vogelbaum, et al.
Neurosurgical Focus|December 1, 2006
Rare pathological variants and presentations of primary central nervous system lymphomasArnaldo Neves Da Silva, Maria Beatriz Lopes, David Schiff
Neuro-Oncology Practice|December 14, 2019
Checkpoint inhibitor failure in hypermutated and mismatch repair-mutated recurrent high-grade gliomasHaroon Ahmad, Camilo E Fadul, David Schiff, et al.
Pageof 31

Showing results (91-100 of 305) with videos related to

Sort By:
Pageof 31
Current Oncology Reports|July 20, 2023
Disease Assessments in Patients with GlioblastomaKester A Phillips, David O Kamson, David Schiff
The Lancet. Neurology|October 22, 2005
Low-grade gliomas: an update on pathology and therapyRobert Cavaliere, Maria Beatriz S Lopes, David Schiff
Cancer|January 7, 2010
Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group ReportRobert Cavaliere, Gina Petroni, Maria B Lopes, et al.
CNS Oncology|October 17, 2017
Regression of an intramedullary spinal cord metastasis with a checkpoint inhibitor: a case reportKester A Phillips, Elizabeth Gaughan, Alejandro Gru, et al.
Surgical Neurology|September 11, 2007
Bone health in patients with brain tumorsArnaldo Neves Da Silva, Ailleen Heras-Herzig, David Schiff
Hematology/Oncology Clinics of North America|October 5, 2021
Central Nervous System Complications Among Oncology PatientsSebastian F Winter, Jasmin Jo, David Schiff, et al.
Endocrine|November 29, 2005
Pituitary carcinoma: diagnosis and treatmentM Beatriz S Lopes, Bernd W Scheithauer, David Schiff
Neuro-Oncology|June 27, 2015
Much debated controversies of diffuse low-grade gliomasGelareh Zadeh, Osaama H Khan, Michael Vogelbaum, et al.
Neurosurgical Focus|December 1, 2006
Rare pathological variants and presentations of primary central nervous system lymphomasArnaldo Neves Da Silva, Maria Beatriz Lopes, David Schiff
Neuro-Oncology Practice|December 14, 2019
Checkpoint inhibitor failure in hypermutated and mismatch repair-mutated recurrent high-grade gliomasHaroon Ahmad, Camilo E Fadul, David Schiff, et al.
Pageof 31